nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—osteoarthritis—Prednisone—systemic lupus erythematosus	0.199	0.5	CpDpCtD
Tolmetin—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.199	0.5	CpDpCtD
Tolmetin—PTGS2—systemic lupus erythematosus	0.17	1	CbGaD
Tolmetin—MPO—Dapsone—systemic lupus erythematosus	0.114	0.384	CbGbCtD
Tolmetin—PTGS2—Dapsone—systemic lupus erythematosus	0.0395	0.133	CbGbCtD
Tolmetin—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0342	0.115	CbGbCtD
Tolmetin—PTGS1—Dapsone—systemic lupus erythematosus	0.0333	0.112	CbGbCtD
Tolmetin—PTGS2—Betamethasone—systemic lupus erythematosus	0.0294	0.0988	CbGbCtD
Tolmetin—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0192	0.0646	CbGbCtD
Tolmetin—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0171	0.0575	CbGbCtD
Tolmetin—SLC22A6—Methotrexate—systemic lupus erythematosus	0.0102	0.0342	CbGbCtD
Tolmetin—MPO—endothelium—systemic lupus erythematosus	0.00169	0.0694	CbGeAlD
Tolmetin—MPO—blood plasma—systemic lupus erythematosus	0.0015	0.0617	CbGeAlD
Tolmetin—TDO2—lung—systemic lupus erythematosus	0.0015	0.0615	CbGeAlD
Tolmetin—TDO2—nervous system—systemic lupus erythematosus	0.00139	0.057	CbGeAlD
Tolmetin—TDO2—central nervous system—systemic lupus erythematosus	0.00133	0.0548	CbGeAlD
Tolmetin—CXCL8—nephron tubule—systemic lupus erythematosus	0.00132	0.0544	CbGeAlD
Tolmetin—SLC22A6—nephron tubule—systemic lupus erythematosus	0.00103	0.0425	CbGeAlD
Tolmetin—CXCL8—bone marrow—systemic lupus erythematosus	0.000909	0.0374	CbGeAlD
Tolmetin—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000884	0.0363	CbGeAlD
Tolmetin—CXCL8—lung—systemic lupus erythematosus	0.000824	0.0339	CbGeAlD
Tolmetin—PTGS1—endothelium—systemic lupus erythematosus	0.000801	0.0329	CbGeAlD
Tolmetin—MPO—connective tissue—systemic lupus erythematosus	0.000798	0.0328	CbGeAlD
Tolmetin—PTGS2—endothelium—systemic lupus erythematosus	0.000766	0.0315	CbGeAlD
Tolmetin—MPO—skin of body—systemic lupus erythematosus	0.000721	0.0296	CbGeAlD
Tolmetin—PTGS1—blood plasma—systemic lupus erythematosus	0.000711	0.0293	CbGeAlD
Tolmetin—PTGS2—blood plasma—systemic lupus erythematosus	0.00068	0.028	CbGeAlD
Tolmetin—MPO—kidney—systemic lupus erythematosus	0.00068	0.0279	CbGeAlD
Tolmetin—MPO—lymphoid tissue—systemic lupus erythematosus	0.000584	0.024	CbGeAlD
Tolmetin—MPO—bone marrow—systemic lupus erythematosus	0.000532	0.0219	CbGeAlD
Tolmetin—MPO—lung—systemic lupus erythematosus	0.000482	0.0198	CbGeAlD
Tolmetin—MPO—nervous system—systemic lupus erythematosus	0.000446	0.0183	CbGeAlD
Tolmetin—MPO—central nervous system—systemic lupus erythematosus	0.000429	0.0177	CbGeAlD
Tolmetin—PTGS1—connective tissue—systemic lupus erythematosus	0.000379	0.0156	CbGeAlD
Tolmetin—PTGS2—connective tissue—systemic lupus erythematosus	0.000362	0.0149	CbGeAlD
Tolmetin—PTGS1—skin of body—systemic lupus erythematosus	0.000342	0.0141	CbGeAlD
Tolmetin—Ketorolac—PTGS2—systemic lupus erythematosus	0.000333	0.172	CrCbGaD
Tolmetin—PTGS2—skin of body—systemic lupus erythematosus	0.000327	0.0134	CbGeAlD
Tolmetin—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000325	0.159	CbGdCrCtD
Tolmetin—PTGS1—kidney—systemic lupus erythematosus	0.000322	0.0133	CbGeAlD
Tolmetin—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.00032	0.156	CbGdCrCtD
Tolmetin—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.00032	0.156	CbGdCrCtD
Tolmetin—Bromfenac—PTGS2—systemic lupus erythematosus	0.00032	0.165	CrCbGaD
Tolmetin—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000312	0.153	CbGdCrCtD
Tolmetin—Indomethacin—PPARG—systemic lupus erythematosus	0.00031	0.16	CrCbGaD
Tolmetin—PTGS2—kidney—systemic lupus erythematosus	0.000308	0.0127	CbGeAlD
Tolmetin—Urinary tract infection—Leflunomide—systemic lupus erythematosus	0.000272	0.00586	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—systemic lupus erythematosus	0.000272	0.14	CrCbGaD
Tolmetin—Visual disturbance—Prednisolone—systemic lupus erythematosus	0.000269	0.00579	CcSEcCtD
Tolmetin—Haematuria—Leflunomide—systemic lupus erythematosus	0.000267	0.00575	CcSEcCtD
Tolmetin—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000265	0.0109	CbGeAlD
Tolmetin—Body temperature increased—Dapsone—systemic lupus erythematosus	0.000264	0.00569	CcSEcCtD
Tolmetin—Abdominal pain—Dapsone—systemic lupus erythematosus	0.000264	0.00569	CcSEcCtD
Tolmetin—Epistaxis—Leflunomide—systemic lupus erythematosus	0.000264	0.00568	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Prednisolone—systemic lupus erythematosus	0.000263	0.00567	CcSEcCtD
Tolmetin—Vascular purpura—Triamcinolone—systemic lupus erythematosus	0.000262	0.00565	CcSEcCtD
Tolmetin—Agranulocytosis—Leflunomide—systemic lupus erythematosus	0.000261	0.00562	CcSEcCtD
Tolmetin—PTGS1—tendon—systemic lupus erythematosus	0.00026	0.0107	CbGeAlD
Tolmetin—Cardiac failure congestive—Triamcinolone—systemic lupus erythematosus	0.000259	0.00557	CcSEcCtD
Tolmetin—Cardiac failure congestive—Methylprednisolone—systemic lupus erythematosus	0.000258	0.00556	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Hydrocortisone—systemic lupus erythematosus	0.000257	0.00554	CcSEcCtD
Tolmetin—Erythema multiforme—Azathioprine—systemic lupus erythematosus	0.000251	0.00542	CcSEcCtD
Tolmetin—Hepatitis—Leflunomide—systemic lupus erythematosus	0.000251	0.00541	CcSEcCtD
Tolmetin—PTGS2—tendon—systemic lupus erythematosus	0.000249	0.0102	CbGeAlD
Tolmetin—Gastritis—Cyclosporine—systemic lupus erythematosus	0.000248	0.00534	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—systemic lupus erythematosus	0.000247	0.128	CrCbGaD
Tolmetin—Purpura—Triamcinolone—systemic lupus erythematosus	0.000243	0.00524	CcSEcCtD
Tolmetin—Proteinuria—Methotrexate—systemic lupus erythematosus	0.000243	0.00523	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Triamcinolone—systemic lupus erythematosus	0.000242	0.00522	CcSEcCtD
Tolmetin—Gastritis—Mycophenolate mofetil—systemic lupus erythematosus	0.000242	0.00521	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Methylprednisolone—systemic lupus erythematosus	0.000242	0.00521	CcSEcCtD
Tolmetin—PTGS2—bone marrow—systemic lupus erythematosus	0.000241	0.00991	CbGeAlD
Tolmetin—Protein urine present—Methotrexate—systemic lupus erythematosus	0.000239	0.00516	CcSEcCtD
Tolmetin—Erythema multiforme—Leflunomide—systemic lupus erythematosus	0.000238	0.00511	CcSEcCtD
Tolmetin—Cardiac failure congestive—Betamethasone—systemic lupus erythematosus	0.000235	0.00505	CcSEcCtD
Tolmetin—Cardiac failure congestive—Dexamethasone—systemic lupus erythematosus	0.000235	0.00505	CcSEcCtD
Tolmetin—Abdominal discomfort—Cyclosporine—systemic lupus erythematosus	0.000232	0.005	CcSEcCtD
Tolmetin—Glossitis—Methotrexate—systemic lupus erythematosus	0.000231	0.00499	CcSEcCtD
Tolmetin—PTGS1—lung—systemic lupus erythematosus	0.000228	0.00939	CbGeAlD
Tolmetin—Dysuria—Cyclosporine—systemic lupus erythematosus	0.000226	0.00488	CcSEcCtD
Tolmetin—Visual disturbance—Dexamethasone—systemic lupus erythematosus	0.000225	0.00484	CcSEcCtD
Tolmetin—Visual disturbance—Betamethasone—systemic lupus erythematosus	0.000225	0.00484	CcSEcCtD
Tolmetin—Dysuria—Mycophenolate mofetil—systemic lupus erythematosus	0.000221	0.00476	CcSEcCtD
Tolmetin—Weight increased—Cyclosporine—systemic lupus erythematosus	0.00022	0.00475	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Dexamethasone—systemic lupus erythematosus	0.00022	0.00473	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Betamethasone—systemic lupus erythematosus	0.00022	0.00473	CcSEcCtD
Tolmetin—Weight decreased—Cyclosporine—systemic lupus erythematosus	0.000219	0.00472	CcSEcCtD
Tolmetin—PTGS2—lung—systemic lupus erythematosus	0.000218	0.00898	CbGeAlD
Tolmetin—Flatulence—Leflunomide—systemic lupus erythematosus	0.000215	0.00464	CcSEcCtD
Tolmetin—Weight increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000215	0.00463	CcSEcCtD
Tolmetin—Weight decreased—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.0046	CcSEcCtD
Tolmetin—Vomiting—Dapsone—systemic lupus erythematosus	0.000213	0.00458	CcSEcCtD
Tolmetin—Renal failure—Cyclosporine—systemic lupus erythematosus	0.000212	0.00457	CcSEcCtD
Tolmetin—PTGS1—nervous system—systemic lupus erythematosus	0.000212	0.0087	CbGeAlD
Tolmetin—Stomatitis—Cyclosporine—systemic lupus erythematosus	0.00021	0.00453	CcSEcCtD
Tolmetin—Urinary tract infection—Cyclosporine—systemic lupus erythematosus	0.00021	0.00452	CcSEcCtD
Tolmetin—Headache—Dapsone—systemic lupus erythematosus	0.000209	0.00451	CcSEcCtD
Tolmetin—Vascular purpura—Prednisone—systemic lupus erythematosus	0.000207	0.00446	CcSEcCtD
Tolmetin—Renal failure—Mycophenolate mofetil—systemic lupus erythematosus	0.000207	0.00446	CcSEcCtD
Tolmetin—Suprofen—PTGS2—systemic lupus erythematosus	0.000206	0.106	CrCbGaD
Tolmetin—Haematuria—Cyclosporine—systemic lupus erythematosus	0.000206	0.00443	CcSEcCtD
Tolmetin—Stomatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000205	0.00442	CcSEcCtD
Tolmetin—Urinary tract infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000205	0.00441	CcSEcCtD
Tolmetin—Cardiac failure congestive—Prednisone—systemic lupus erythematosus	0.000204	0.0044	CcSEcCtD
Tolmetin—PTGS1—central nervous system—systemic lupus erythematosus	0.000204	0.00838	CbGeAlD
Tolmetin—Epistaxis—Cyclosporine—systemic lupus erythematosus	0.000204	0.00439	CcSEcCtD
Tolmetin—PTGS2—nervous system—systemic lupus erythematosus	0.000202	0.00832	CbGeAlD
Tolmetin—Haematuria—Mycophenolate mofetil—systemic lupus erythematosus	0.000201	0.00433	CcSEcCtD
Tolmetin—Weight increased—Prednisolone—systemic lupus erythematosus	0.000201	0.00432	CcSEcCtD
Tolmetin—Epistaxis—Mycophenolate mofetil—systemic lupus erythematosus	0.000199	0.00428	CcSEcCtD
Tolmetin—Nausea—Dapsone—systemic lupus erythematosus	0.000199	0.00428	CcSEcCtD
Tolmetin—Agranulocytosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000197	0.00423	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000196	0.0957	CbGdCrCtD
Tolmetin—Weight increased—Hydrocortisone—systemic lupus erythematosus	0.000196	0.00422	CcSEcCtD
Tolmetin—Weight decreased—Hydrocortisone—systemic lupus erythematosus	0.000195	0.00419	CcSEcCtD
Tolmetin—PTGS2—central nervous system—systemic lupus erythematosus	0.000195	0.00801	CbGeAlD
Tolmetin—Hepatitis—Cyclosporine—systemic lupus erythematosus	0.000194	0.00417	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000193	0.0942	CbGdCrCtD
Tolmetin—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000193	0.0942	CbGdCrCtD
Tolmetin—Purpura—Prednisone—systemic lupus erythematosus	0.000192	0.00414	CcSEcCtD
Tolmetin—Hepatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000189	0.00407	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000188	0.0921	CbGdCrCtD
Tolmetin—Visual impairment—Cyclosporine—systemic lupus erythematosus	0.000187	0.00402	CcSEcCtD
Tolmetin—Chest pain—Leflunomide—systemic lupus erythematosus	0.000186	0.00401	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Prednisone—systemic lupus erythematosus	0.000185	0.00399	CcSEcCtD
Tolmetin—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000185	0.00398	CcSEcCtD
Tolmetin—Weight increased—Triamcinolone—systemic lupus erythematosus	0.000184	0.00397	CcSEcCtD
Tolmetin—Weight increased—Methylprednisolone—systemic lupus erythematosus	0.000184	0.00396	CcSEcCtD
Tolmetin—Visual impairment—Mycophenolate mofetil—systemic lupus erythematosus	0.000182	0.00392	CcSEcCtD
Tolmetin—Lymphadenopathy—Methotrexate—systemic lupus erythematosus	0.000182	0.00391	CcSEcCtD
Tolmetin—Tinnitus—Cyclosporine—systemic lupus erythematosus	0.000181	0.00389	CcSEcCtD
Tolmetin—Anaphylactic shock—Leflunomide—systemic lupus erythematosus	0.000178	0.00384	CcSEcCtD
Tolmetin—Tinnitus—Mycophenolate mofetil—systemic lupus erythematosus	0.000176	0.0038	CcSEcCtD
Tolmetin—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000175	0.00376	CcSEcCtD
Tolmetin—Epistaxis—Triamcinolone—systemic lupus erythematosus	0.00017	0.00367	CcSEcCtD
Tolmetin—Visual impairment—Prednisolone—systemic lupus erythematosus	0.00017	0.00366	CcSEcCtD
Tolmetin—Weight increased—Betamethasone—systemic lupus erythematosus	0.000167	0.0036	CcSEcCtD
Tolmetin—Weight increased—Dexamethasone—systemic lupus erythematosus	0.000167	0.0036	CcSEcCtD
Tolmetin—Weight decreased—Betamethasone—systemic lupus erythematosus	0.000166	0.00358	CcSEcCtD
Tolmetin—Weight decreased—Dexamethasone—systemic lupus erythematosus	0.000166	0.00358	CcSEcCtD
Tolmetin—Flatulence—Cyclosporine—systemic lupus erythematosus	0.000166	0.00358	CcSEcCtD
Tolmetin—Visual disturbance—Methotrexate—systemic lupus erythematosus	0.000163	0.00352	CcSEcCtD
Tolmetin—Flatulence—Mycophenolate mofetil—systemic lupus erythematosus	0.000162	0.00349	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Methotrexate—systemic lupus erythematosus	0.00016	0.00345	CcSEcCtD
Tolmetin—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.000157	0.00338	CcSEcCtD
Tolmetin—Visual impairment—Methylprednisolone—systemic lupus erythematosus	0.000156	0.00336	CcSEcCtD
Tolmetin—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.000155	0.00333	CcSEcCtD
Tolmetin—Constipation—Leflunomide—systemic lupus erythematosus	0.000153	0.00329	CcSEcCtD
Tolmetin—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000149	0.00322	CcSEcCtD
Tolmetin—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000149	0.00322	CcSEcCtD
Tolmetin—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000146	0.00314	CcSEcCtD
Tolmetin—Weight increased—Prednisone—systemic lupus erythematosus	0.000146	0.00314	CcSEcCtD
Tolmetin—Weight decreased—Prednisone—systemic lupus erythematosus	0.000145	0.00312	CcSEcCtD
Tolmetin—Chest pain—Cyclosporine—systemic lupus erythematosus	0.000144	0.00309	CcSEcCtD
Tolmetin—Visual impairment—Betamethasone—systemic lupus erythematosus	0.000142	0.00305	CcSEcCtD
Tolmetin—Visual impairment—Dexamethasone—systemic lupus erythematosus	0.000142	0.00305	CcSEcCtD
Tolmetin—Urticaria—Leflunomide—systemic lupus erythematosus	0.000142	0.00305	CcSEcCtD
Tolmetin—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000141	0.00304	CcSEcCtD
Tolmetin—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000141	0.00304	CcSEcCtD
Tolmetin—Chest pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.00302	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Methotrexate—systemic lupus erythematosus	0.000139	0.003	CcSEcCtD
Tolmetin—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000138	0.00297	CcSEcCtD
Tolmetin—Oedema—Cyclosporine—systemic lupus erythematosus	0.000138	0.00297	CcSEcCtD
Tolmetin—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000135	0.0029	CcSEcCtD
Tolmetin—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00289	CcSEcCtD
Tolmetin—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00289	CcSEcCtD
Tolmetin—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.00283	CcSEcCtD
Tolmetin—Indomethacin—PTGS2—systemic lupus erythematosus	0.000131	0.0677	CrCbGaD
Tolmetin—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000129	0.00278	CcSEcCtD
Tolmetin—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000128	0.00276	CcSEcCtD
Tolmetin—Asthenia—Leflunomide—systemic lupus erythematosus	0.000128	0.00276	CcSEcCtD
Tolmetin—Oedema—Prednisolone—systemic lupus erythematosus	0.000125	0.0027	CcSEcCtD
Tolmetin—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000125	0.0027	CcSEcCtD
Tolmetin—Dysuria—Methotrexate—systemic lupus erythematosus	0.000125	0.0027	CcSEcCtD
Tolmetin—Dizziness—Azathioprine—systemic lupus erythematosus	0.000125	0.00269	CcSEcCtD
Tolmetin—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000122	0.00264	CcSEcCtD
Tolmetin—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000122	0.00264	CcSEcCtD
Tolmetin—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000122	0.00264	CcSEcCtD
Tolmetin—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000122	0.00263	CcSEcCtD
Tolmetin—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000121	0.00261	CcSEcCtD
Tolmetin—Vomiting—Azathioprine—systemic lupus erythematosus	0.00012	0.00259	CcSEcCtD
Tolmetin—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000119	0.00257	CcSEcCtD
Tolmetin—Drowsiness—Methotrexate—systemic lupus erythematosus	0.000119	0.00257	CcSEcCtD
Tolmetin—Headache—Azathioprine—systemic lupus erythematosus	0.000118	0.00255	CcSEcCtD
Tolmetin—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.00255	CcSEcCtD
Tolmetin—Dizziness—Leflunomide—systemic lupus erythematosus	0.000118	0.00254	CcSEcCtD
Tolmetin—Constipation—Cyclosporine—systemic lupus erythematosus	0.000118	0.00254	CcSEcCtD
Tolmetin—Renal failure—Methotrexate—systemic lupus erythematosus	0.000117	0.00253	CcSEcCtD
Tolmetin—Indomethacin—ALB—systemic lupus erythematosus	0.000117	0.0603	CrCbGaD
Tolmetin—Stomatitis—Methotrexate—systemic lupus erythematosus	0.000116	0.00251	CcSEcCtD
Tolmetin—Oedema—Triamcinolone—systemic lupus erythematosus	0.000115	0.00248	CcSEcCtD
Tolmetin—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000115	0.00248	CcSEcCtD
Tolmetin—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000115	0.00248	CcSEcCtD
Tolmetin—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000115	0.00247	CcSEcCtD
Tolmetin—Haematuria—Methotrexate—systemic lupus erythematosus	0.000114	0.00245	CcSEcCtD
Tolmetin—Vomiting—Leflunomide—systemic lupus erythematosus	0.000113	0.00244	CcSEcCtD
Tolmetin—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000113	0.00243	CcSEcCtD
Tolmetin—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000113	0.00242	CcSEcCtD
Tolmetin—Nausea—Azathioprine—systemic lupus erythematosus	0.000112	0.00242	CcSEcCtD
Tolmetin—Headache—Leflunomide—systemic lupus erythematosus	0.000112	0.00241	CcSEcCtD
Tolmetin—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000111	0.0024	CcSEcCtD
Tolmetin—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00011	0.00237	CcSEcCtD
Tolmetin—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000109	0.00236	CcSEcCtD
Tolmetin—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000109	0.00234	CcSEcCtD
Tolmetin—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000109	0.00234	CcSEcCtD
Tolmetin—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000108	0.00232	CcSEcCtD
Tolmetin—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000107	0.00231	CcSEcCtD
Tolmetin—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000107	0.0023	CcSEcCtD
Tolmetin—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.00229	CcSEcCtD
Tolmetin—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.00229	CcSEcCtD
Tolmetin—Nausea—Leflunomide—systemic lupus erythematosus	0.000106	0.00228	CcSEcCtD
Tolmetin—Oedema—Betamethasone—systemic lupus erythematosus	0.000105	0.00225	CcSEcCtD
Tolmetin—Oedema—Dexamethasone—systemic lupus erythematosus	0.000105	0.00225	CcSEcCtD
Tolmetin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000105	0.00225	CcSEcCtD
Tolmetin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000105	0.00225	CcSEcCtD
Tolmetin—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000103	0.00222	CcSEcCtD
Tolmetin—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000102	0.00221	CcSEcCtD
Tolmetin—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000102	0.00221	CcSEcCtD
Tolmetin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000101	0.00218	CcSEcCtD
Tolmetin—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000101	0.00218	CcSEcCtD
Tolmetin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000101	0.00218	CcSEcCtD
Tolmetin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.0001	0.00216	CcSEcCtD
Tolmetin—Tinnitus—Methotrexate—systemic lupus erythematosus	9.99e-05	0.00215	CcSEcCtD
Tolmetin—Urticaria—Prednisolone—systemic lupus erythematosus	9.96e-05	0.00214	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—EP300—systemic lupus erythematosus	9.96e-05	0.00166	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CDKN1B—systemic lupus erythematosus	9.89e-05	0.00165	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IFNG—systemic lupus erythematosus	9.89e-05	0.00165	CbGpPWpGaD
Tolmetin—Asthenia—Cyclosporine—systemic lupus erythematosus	9.88e-05	0.00213	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	9.88e-05	0.00164	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	9.87e-05	0.00164	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—MMP9—systemic lupus erythematosus	9.84e-05	0.00164	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TLR4—systemic lupus erythematosus	9.83e-05	0.00164	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	9.75e-05	0.00162	CbGpPWpGaD
Tolmetin—Urticaria—Hydrocortisone—systemic lupus erythematosus	9.72e-05	0.00209	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL2—systemic lupus erythematosus	9.68e-05	0.00161	CbGpPWpGaD
Tolmetin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	9.68e-05	0.00208	CcSEcCtD
Tolmetin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	9.68e-05	0.00208	CcSEcCtD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	9.65e-05	0.00161	CbGpPWpGaD
Tolmetin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	9.64e-05	0.00208	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IFNG—systemic lupus erythematosus	9.59e-05	0.0016	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—systemic lupus erythematosus	9.47e-05	0.00158	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	9.46e-05	0.00157	CbGpPWpGaD
Tolmetin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	9.42e-05	0.00203	CcSEcCtD
Tolmetin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	9.4e-05	0.00203	CcSEcCtD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	9.27e-05	0.00154	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	9.23e-05	0.00154	CbGpPWpGaD
Tolmetin—Dyspepsia—Betamethasone—systemic lupus erythematosus	9.21e-05	0.00198	CcSEcCtD
Tolmetin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	9.21e-05	0.00198	CcSEcCtD
Tolmetin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	9.19e-05	0.00198	CcSEcCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—NOS3—systemic lupus erythematosus	9.17e-05	0.00153	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MMP9—systemic lupus erythematosus	9.16e-05	0.00152	CbGpPWpGaD
Tolmetin—Urticaria—Triamcinolone—systemic lupus erythematosus	9.16e-05	0.00197	CcSEcCtD
Tolmetin—Urticaria—Methylprednisolone—systemic lupus erythematosus	9.14e-05	0.00197	CcSEcCtD
Tolmetin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	9.11e-05	0.00196	CcSEcCtD
Tolmetin—Dizziness—Cyclosporine—systemic lupus erythematosus	9.11e-05	0.00196	CcSEcCtD
Tolmetin—Oedema—Prednisone—systemic lupus erythematosus	9.11e-05	0.00196	CcSEcCtD
Tolmetin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	9.11e-05	0.00196	CcSEcCtD
Tolmetin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	9.09e-05	0.00196	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	9.03e-05	0.0015	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	8.91e-05	0.00148	CbGpPWpGaD
Tolmetin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	8.88e-05	0.00191	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL2—systemic lupus erythematosus	8.78e-05	0.00146	CbGpPWpGaD
Tolmetin—Asthenia—Hydrocortisone—systemic lupus erythematosus	8.78e-05	0.00189	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	8.76e-05	0.00146	CbGpPWpGaD
Tolmetin—Vomiting—Cyclosporine—systemic lupus erythematosus	8.76e-05	0.00189	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—EP300—systemic lupus erythematosus	8.68e-05	0.00145	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	8.65e-05	0.00144	CbGpPWpGaD
Tolmetin—Headache—Cyclosporine—systemic lupus erythematosus	8.63e-05	0.00186	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR4—systemic lupus erythematosus	8.62e-05	0.00143	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	8.58e-05	0.00143	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	8.55e-05	0.00184	CcSEcCtD
Tolmetin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	8.55e-05	0.00184	CcSEcCtD
Tolmetin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	8.54e-05	0.00184	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL2—systemic lupus erythematosus	8.53e-05	0.00142	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CCL2—systemic lupus erythematosus	8.43e-05	0.0014	CbGpPWpGaD
Tolmetin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	8.42e-05	0.00181	CcSEcCtD
Tolmetin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	8.38e-05	0.0018	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—P2RY12—systemic lupus erythematosus	8.34e-05	0.00139	CbGpPWpGaD
Tolmetin—Urticaria—Betamethasone—systemic lupus erythematosus	8.31e-05	0.00179	CcSEcCtD
Tolmetin—Urticaria—Dexamethasone—systemic lupus erythematosus	8.31e-05	0.00179	CcSEcCtD
Tolmetin—Dizziness—Prednisolone—systemic lupus erythematosus	8.29e-05	0.00178	CcSEcCtD
Tolmetin—Asthenia—Triamcinolone—systemic lupus erythematosus	8.27e-05	0.00178	CcSEcCtD
Tolmetin—Body temperature increased—Betamethasone—systemic lupus erythematosus	8.27e-05	0.00178	CcSEcCtD
Tolmetin—Abdominal pain—Betamethasone—systemic lupus erythematosus	8.27e-05	0.00178	CcSEcCtD
Tolmetin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	8.27e-05	0.00178	CcSEcCtD
Tolmetin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	8.27e-05	0.00178	CcSEcCtD
Tolmetin—Asthenia—Methylprednisolone—systemic lupus erythematosus	8.25e-05	0.00178	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	8.23e-05	0.00137	CbGpPWpGaD
Tolmetin—Nausea—Cyclosporine—systemic lupus erythematosus	8.18e-05	0.00176	CcSEcCtD
Tolmetin—Dizziness—Hydrocortisone—systemic lupus erythematosus	8.09e-05	0.00174	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—CDKN1A—systemic lupus erythematosus	8.04e-05	0.00134	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL6—systemic lupus erythematosus	8.04e-05	0.00134	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NAT2—systemic lupus erythematosus	8.02e-05	0.00133	CbGpPWpGaD
Tolmetin—Dyspepsia—Prednisone—systemic lupus erythematosus	8.02e-05	0.00173	CcSEcCtD
Tolmetin—CXCL8—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	8e-05	0.00133	CbGpPWpGaD
Tolmetin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	7.98e-05	0.00172	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CD80—systemic lupus erythematosus	7.96e-05	0.00132	CbGpPWpGaD
Tolmetin—Chest pain—Methotrexate—systemic lupus erythematosus	7.94e-05	0.00171	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	7.91e-05	0.00132	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IFNG—systemic lupus erythematosus	7.87e-05	0.00131	CbGpPWpGaD
Tolmetin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	7.87e-05	0.00169	CcSEcCtD
Tolmetin—Headache—Prednisolone—systemic lupus erythematosus	7.85e-05	0.00169	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—systemic lupus erythematosus	7.82e-05	0.0013	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	7.8e-05	0.0013	CbGpPWpGaD
Tolmetin—Constipation—Prednisone—systemic lupus erythematosus	7.79e-05	0.00168	CcSEcCtD
Tolmetin—Vomiting—Hydrocortisone—systemic lupus erythematosus	7.78e-05	0.00168	CcSEcCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL2—systemic lupus erythematosus	7.78e-05	0.00129	CbGpPWpGaD
Tolmetin—Headache—Hydrocortisone—systemic lupus erythematosus	7.67e-05	0.00165	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—EP300—systemic lupus erythematosus	7.65e-05	0.00127	CbGpPWpGaD
Tolmetin—Dizziness—Triamcinolone—systemic lupus erythematosus	7.62e-05	0.00164	CcSEcCtD
Tolmetin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	7.61e-05	0.00164	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	7.61e-05	0.00127	CbGpPWpGaD
Tolmetin—Dizziness—Methylprednisolone—systemic lupus erythematosus	7.6e-05	0.00164	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	7.55e-05	0.00126	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	7.54e-05	0.00125	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	7.53e-05	0.00125	CbGpPWpGaD
Tolmetin—Asthenia—Dexamethasone—systemic lupus erythematosus	7.5e-05	0.00162	CcSEcCtD
Tolmetin—Asthenia—Betamethasone—systemic lupus erythematosus	7.5e-05	0.00162	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—VEGFA—systemic lupus erythematosus	7.47e-05	0.00124	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	7.45e-05	0.0016	CcSEcCtD
Tolmetin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	7.45e-05	0.0016	CcSEcCtD
Tolmetin—Nausea—Prednisolone—systemic lupus erythematosus	7.44e-05	0.0016	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	7.37e-05	0.00123	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	7.36e-05	0.00123	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	7.34e-05	0.00122	CbGpPWpGaD
Tolmetin—Vomiting—Triamcinolone—systemic lupus erythematosus	7.33e-05	0.00158	CcSEcCtD
Tolmetin—Vomiting—Methylprednisolone—systemic lupus erythematosus	7.31e-05	0.00157	CcSEcCtD
Tolmetin—Nausea—Hydrocortisone—systemic lupus erythematosus	7.27e-05	0.00157	CcSEcCtD
Tolmetin—Urticaria—Prednisone—systemic lupus erythematosus	7.24e-05	0.00156	CcSEcCtD
Tolmetin—Headache—Triamcinolone—systemic lupus erythematosus	7.22e-05	0.00155	CcSEcCtD
Tolmetin—Headache—Methylprednisolone—systemic lupus erythematosus	7.2e-05	0.00155	CcSEcCtD
Tolmetin—Abdominal pain—Prednisone—systemic lupus erythematosus	7.2e-05	0.00155	CcSEcCtD
Tolmetin—Body temperature increased—Prednisone—systemic lupus erythematosus	7.2e-05	0.00155	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—IFNG—systemic lupus erythematosus	7.17e-05	0.00119	CbGpPWpGaD
Tolmetin—Diarrhoea—Betamethasone—systemic lupus erythematosus	7.16e-05	0.00154	CcSEcCtD
Tolmetin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	7.16e-05	0.00154	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	7.15e-05	0.00119	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN1B—systemic lupus erythematosus	7.15e-05	0.00119	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1B—systemic lupus erythematosus	7.15e-05	0.00119	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	7.07e-05	0.00118	CbGpPWpGaD
Tolmetin—Dizziness—Dexamethasone—systemic lupus erythematosus	6.92e-05	0.00149	CcSEcCtD
Tolmetin—Dizziness—Betamethasone—systemic lupus erythematosus	6.92e-05	0.00149	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—PTGS2—systemic lupus erythematosus	6.88e-05	0.00114	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TGFB1—systemic lupus erythematosus	6.85e-05	0.00114	CbGpPWpGaD
Tolmetin—Nausea—Triamcinolone—systemic lupus erythematosus	6.85e-05	0.00147	CcSEcCtD
Tolmetin—Nausea—Methylprednisolone—systemic lupus erythematosus	6.83e-05	0.00147	CcSEcCtD
Tolmetin—Somnolence—Methotrexate—systemic lupus erythematosus	6.77e-05	0.00146	CcSEcCtD
Tolmetin—Dyspepsia—Methotrexate—systemic lupus erythematosus	6.7e-05	0.00144	CcSEcCtD
Tolmetin—Vomiting—Betamethasone—systemic lupus erythematosus	6.65e-05	0.00143	CcSEcCtD
Tolmetin—Vomiting—Dexamethasone—systemic lupus erythematosus	6.65e-05	0.00143	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	6.6e-05	0.0011	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1A—systemic lupus erythematosus	6.6e-05	0.0011	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN1A—systemic lupus erythematosus	6.6e-05	0.0011	CbGpPWpGaD
Tolmetin—Headache—Betamethasone—systemic lupus erythematosus	6.55e-05	0.00141	CcSEcCtD
Tolmetin—Headache—Dexamethasone—systemic lupus erythematosus	6.55e-05	0.00141	CcSEcCtD
Tolmetin—Asthenia—Prednisone—systemic lupus erythematosus	6.53e-05	0.00141	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—systemic lupus erythematosus	6.52e-05	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	6.51e-05	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	6.46e-05	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—systemic lupus erythematosus	6.4e-05	0.00106	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	6.39e-05	0.00106	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL2—systemic lupus erythematosus	6.37e-05	0.00106	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	6.36e-05	0.00106	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	6.24e-05	0.00104	CbGpPWpGaD
Tolmetin—Diarrhoea—Prednisone—systemic lupus erythematosus	6.23e-05	0.00134	CcSEcCtD
Tolmetin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	6.22e-05	0.00134	CcSEcCtD
Tolmetin—Nausea—Betamethasone—systemic lupus erythematosus	6.21e-05	0.00134	CcSEcCtD
Tolmetin—Nausea—Dexamethasone—systemic lupus erythematosus	6.21e-05	0.00134	CcSEcCtD
Tolmetin—CXCL8—G alpha (i) signalling events—C3—systemic lupus erythematosus	6.21e-05	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TGFB1—systemic lupus erythematosus	6.07e-05	0.00101	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	6.06e-05	0.00101	CbGpPWpGaD
Tolmetin—Urticaria—Methotrexate—systemic lupus erythematosus	6.05e-05	0.0013	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—MMP9—systemic lupus erythematosus	6.03e-05	0.001	CbGpPWpGaD
Tolmetin—Dizziness—Prednisone—systemic lupus erythematosus	6.02e-05	0.0013	CcSEcCtD
Tolmetin—Body temperature increased—Methotrexate—systemic lupus erythematosus	6.02e-05	0.0013	CcSEcCtD
Tolmetin—Abdominal pain—Methotrexate—systemic lupus erythematosus	6.02e-05	0.0013	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	5.88e-05	0.000979	CbGpPWpGaD
Tolmetin—Vomiting—Prednisone—systemic lupus erythematosus	5.79e-05	0.00125	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	5.76e-05	0.000959	CbGpPWpGaD
Tolmetin—Headache—Prednisone—systemic lupus erythematosus	5.71e-05	0.00123	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—systemic lupus erythematosus	5.69e-05	0.000947	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	5.68e-05	0.000945	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	5.65e-05	0.00094	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCL12—systemic lupus erythematosus	5.61e-05	0.000934	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	5.59e-05	0.000931	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	5.55e-05	0.000923	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	5.48e-05	0.000913	CbGpPWpGaD
Tolmetin—Asthenia—Methotrexate—systemic lupus erythematosus	5.46e-05	0.00118	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TGFB1—systemic lupus erythematosus	5.46e-05	0.000908	CbGpPWpGaD
Tolmetin—Nausea—Prednisone—systemic lupus erythematosus	5.41e-05	0.00116	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	5.32e-05	0.000886	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	5.24e-05	0.000872	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—systemic lupus erythematosus	5.22e-05	0.000868	CbGpPWpGaD
Tolmetin—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.21e-05	0.00112	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	5.2e-05	0.000865	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	5.05e-05	0.000841	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	5.04e-05	0.000839	CbGpPWpGaD
Tolmetin—Dizziness—Methotrexate—systemic lupus erythematosus	5.03e-05	0.00108	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—systemic lupus erythematosus	5.01e-05	0.000834	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	5e-05	0.000833	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.99e-05	0.000831	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	4.97e-05	0.000827	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	4.94e-05	0.000822	CbGpPWpGaD
Tolmetin—Vomiting—Methotrexate—systemic lupus erythematosus	4.84e-05	0.00104	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	4.8e-05	0.000798	CbGpPWpGaD
Tolmetin—Headache—Methotrexate—systemic lupus erythematosus	4.77e-05	0.00103	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	4.72e-05	0.000785	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	4.71e-05	0.000783	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	4.67e-05	0.000777	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—systemic lupus erythematosus	4.64e-05	0.000772	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	4.57e-05	0.000761	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN1B—systemic lupus erythematosus	4.52e-05	0.000753	CbGpPWpGaD
Tolmetin—Nausea—Methotrexate—systemic lupus erythematosus	4.52e-05	0.000974	CcSEcCtD
Tolmetin—TDO2—Metabolism—RXRA—systemic lupus erythematosus	4.49e-05	0.000748	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	4.35e-05	0.000724	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	4.34e-05	0.000722	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	4.33e-05	0.000721	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.32e-05	0.000719	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	4.31e-05	0.000717	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—P2RY12—systemic lupus erythematosus	4.28e-05	0.000713	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—systemic lupus erythematosus	4.21e-05	0.0007	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN1A—systemic lupus erythematosus	4.18e-05	0.000695	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	4.12e-05	0.000686	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—systemic lupus erythematosus	4.11e-05	0.000684	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—systemic lupus erythematosus	4.11e-05	0.000684	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—systemic lupus erythematosus	4.07e-05	0.000678	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	4.04e-05	0.000673	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	3.98e-05	0.000663	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	3.97e-05	0.000661	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—ACE—systemic lupus erythematosus	3.96e-05	0.00066	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	3.86e-05	0.000643	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCR5—systemic lupus erythematosus	3.85e-05	0.00064	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—C3—systemic lupus erythematosus	3.76e-05	0.000626	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—systemic lupus erythematosus	3.75e-05	0.000623	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	3.74e-05	0.000623	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	3.71e-05	0.000618	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	3.69e-05	0.000615	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	3.45e-05	0.000575	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1B—systemic lupus erythematosus	3.42e-05	0.000569	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.38e-05	0.000562	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—F2—systemic lupus erythematosus	3.3e-05	0.000549	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	3.29e-05	0.000547	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	3.29e-05	0.000547	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.26e-05	0.000542	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	3.24e-05	0.000539	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	3.17e-05	0.000528	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1A—systemic lupus erythematosus	3.16e-05	0.000525	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	3.14e-05	0.000523	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—EP300—systemic lupus erythematosus	3e-05	0.0005	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	3e-05	0.000499	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	2.96e-05	0.000492	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCL2—systemic lupus erythematosus	2.94e-05	0.00049	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCL12—systemic lupus erythematosus	2.88e-05	0.00048	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	2.85e-05	0.000475	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.85e-05	0.000474	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—systemic lupus erythematosus	2.84e-05	0.000473	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PPARG—systemic lupus erythematosus	2.84e-05	0.000472	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	2.79e-05	0.000465	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	2.69e-05	0.000447	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	2.64e-05	0.00044	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.61e-05	0.000435	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TLR9—systemic lupus erythematosus	2.61e-05	0.000435	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—systemic lupus erythematosus	2.6e-05	0.000433	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	2.57e-05	0.000428	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ALB—systemic lupus erythematosus	2.55e-05	0.000425	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.55e-05	0.000424	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.53e-05	0.000421	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NOS3—systemic lupus erythematosus	2.44e-05	0.000406	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.39e-05	0.000398	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CSK—systemic lupus erythematosus	2.33e-05	0.000387	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—F2—systemic lupus erythematosus	2.32e-05	0.000387	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.3e-05	0.000382	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—systemic lupus erythematosus	2.23e-05	0.000372	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	2.18e-05	0.000362	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR5—systemic lupus erythematosus	2.17e-05	0.000362	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.17e-05	0.000361	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	2.14e-05	0.000357	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NCF2—systemic lupus erythematosus	2.13e-05	0.000354	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—C3—systemic lupus erythematosus	2.13e-05	0.000354	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LYN—systemic lupus erythematosus	2.12e-05	0.000352	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.08e-05	0.000347	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.07e-05	0.000345	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.07e-05	0.000345	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CCL2—systemic lupus erythematosus	2.07e-05	0.000345	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	2.03e-05	0.000338	CbGpPWpGaD
Tolmetin—PTGS2—Disease—XRCC6—systemic lupus erythematosus	2.03e-05	0.000337	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.97e-05	0.000329	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—systemic lupus erythematosus	1.97e-05	0.000327	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.95e-05	0.000324	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.94e-05	0.000323	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—C3—systemic lupus erythematosus	1.93e-05	0.000321	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—F2—systemic lupus erythematosus	1.87e-05	0.000311	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—EP300—systemic lupus erythematosus	1.86e-05	0.000309	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.79e-05	0.000298	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	1.72e-05	0.000287	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.72e-05	0.000287	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.7e-05	0.000284	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.7e-05	0.000283	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—F2—systemic lupus erythematosus	1.69e-05	0.000282	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JUNB—systemic lupus erythematosus	1.67e-05	0.000278	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	1.64e-05	0.000273	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.61e-05	0.000269	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.59e-05	0.000264	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRL—systemic lupus erythematosus	1.54e-05	0.000256	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.51e-05	0.000251	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	1.49e-05	0.000249	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.48e-05	0.000247	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CSK—systemic lupus erythematosus	1.46e-05	0.000242	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.45e-05	0.000241	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.38e-05	0.00023	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.37e-05	0.000228	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.37e-05	0.000228	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD247—systemic lupus erythematosus	1.37e-05	0.000228	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	1.37e-05	0.000228	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NCF2—systemic lupus erythematosus	1.33e-05	0.000222	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.26e-05	0.000209	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.23e-05	0.000205	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAK1—systemic lupus erythematosus	1.23e-05	0.000205	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR5—systemic lupus erythematosus	1.17e-05	0.000194	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.15e-05	0.000191	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—systemic lupus erythematosus	1.14e-05	0.00019	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—C3—systemic lupus erythematosus	1.14e-05	0.00019	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.09e-05	0.000181	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.08e-05	0.000179	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JUNB—systemic lupus erythematosus	1.05e-05	0.000174	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—F2—systemic lupus erythematosus	1e-05	0.000167	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.78e-06	0.000163	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	9.66e-06	0.000161	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PRL—systemic lupus erythematosus	9.63e-06	0.00016	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CD80—systemic lupus erythematosus	9.6e-06	0.00016	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.96e-06	0.000149	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL2—systemic lupus erythematosus	8.92e-06	0.000148	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TYK2—systemic lupus erythematosus	8.1e-06	0.000135	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOS3—systemic lupus erythematosus	7.95e-06	0.000132	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JAK1—systemic lupus erythematosus	7.7e-06	0.000128	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	7.67e-06	0.000128	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CCR5—systemic lupus erythematosus	7.3e-06	0.000121	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.12e-06	0.000118	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.89e-06	0.000115	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—systemic lupus erythematosus	6.74e-06	0.000112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—systemic lupus erythematosus	6.71e-06	0.000112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—systemic lupus erythematosus	6.38e-06	0.000106	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.36e-06	0.000106	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	6.1e-06	0.000102	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EP300—systemic lupus erythematosus	6.05e-06	0.000101	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD80—systemic lupus erythematosus	6e-06	9.99e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.73e-06	9.53e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—systemic lupus erythematosus	5.49e-06	9.13e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.26e-06	8.75e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	5.25e-06	8.73e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TYK2—systemic lupus erythematosus	5.07e-06	8.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS3—systemic lupus erythematosus	4.97e-06	8.28e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	4.84e-06	8.06e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	4.8e-06	7.99e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—systemic lupus erythematosus	4.58e-06	7.63e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—systemic lupus erythematosus	4.35e-06	7.25e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	4.31e-06	7.17e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	4.17e-06	6.93e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—EP300—systemic lupus erythematosus	3.99e-06	6.64e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	3.98e-06	6.62e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—systemic lupus erythematosus	3.96e-06	6.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EP300—systemic lupus erythematosus	3.78e-06	6.3e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—systemic lupus erythematosus	3.29e-06	5.47e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—EP300—systemic lupus erythematosus	3.17e-06	5.27e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—systemic lupus erythematosus	2.48e-06	4.12e-05	CbGpPWpGaD
